← SynDRA
FISOGATINIB
SynDRA canonical compound SYN0039901 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | FGFR4 |
| Mechanism of action | fibroblast growth factor inhibitor |
All known targets
Mechanisms of action (all sources)
- fibroblast growth factor inhibitor
- FGFR4 INHIBITOR
Drug classes
Cross-references
Synonyms
- BLU-111362
- BLU-554
- BLU111362
- X-439161
- X439161
- MGZKYOAQVGSSGC-DLBZAZTESA-N
- N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide
- BLU554
- SCHEMBL16668287
- EX-A841
- MolPort-044-727-735
- s8503
- AKOS030632994
- CS-5986
- ACN-037513
- AC-29871
- HY-100492
- N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]tetrahydro-2H-pyran-4-yl]-2-propenamide
- BLU 554
- 5Q7R99CKV2
- CS3008
- fisogatinibum
- RefChem:921622
- CS-3008
- Fibroblast Growth Factor Receptor 4 Inhibitor BLU-554
- Fisogatinib [INN]
- Fisogatinib [USAN]
- MFCD30496704
- C24H24Cl2N4O4
- BLU554(Fisogatinib)
- BLU554(Fisogatinib)?
- Fisogatinib (USAN/INN)
- Fisogatinib [USAN:INN]
- Fisogatinib (BLU-554)
- UNII-5Q7R99CKV2
- FISOGATINIB [WHO-DD]
- orb1304186
- BLU 554 [WHO-DD]
- GTPL10220
Look up FISOGATINIB in the interactive SynDRA portal →